BRISTOL MYERS SQUIBB
“BREATHE”

BMS launched the Lung Cancer Research campaign to create awareness of their continuing commitment to finding new ways to fight cancer. This was an integrated effort that set the stage for the first FDA-approved immunotherapy combination for newly diagnosed advanced non-small cell lung cancer.